Current Status Regarding Immunosuppressive Treatment in Patients after Renal Transplantation.

This review summarizes the current status of immunosuppressive therapy after renal transplantation, where personalized triple-drug maintenance based on calcineurin inhibitors, corticosteroids, and antiproliferative agents remains standard, with ongoing efforts to develop regimens that reduce toxicity and side effects.